Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

Estimating the cost-effectiveness of needle-syringe programs in Australia.

Kwon JA, Anderson J, Kerr CC, Thein HH, Zhang L, Iversen J, Dore GJ, Kaldor JM, Law MG, Maher L, Wilson DP.

AIDS. 2012 Nov 13;26(17):2201-10. doi: 10.1097/QAD.0b013e3283578b5d.

PMID:
22914579
2.

The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis.

Kwon JA, Iversen J, Maher L, Law MG, Wilson DP.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):462-9. doi: 10.1097/QAI.0b013e3181a2539a.

PMID:
19387355
3.

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.

PMID:
17854731
4.

Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment.

Nguyen TQ, Weir BW, Des Jarlais DC, Pinkerton SD, Holtgrave DR.

AIDS Behav. 2014 Nov;18(11):2144-55. doi: 10.1007/s10461-014-0789-9.

5.

Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.

Iversen J, Topp L, Wand H, Maher L.

Drug Alcohol Depend. 2012 May 1;122(3):195-200. doi: 10.1016/j.drugalcdep.2011.09.030. Epub 2011 Nov 8.

PMID:
22071120
6.

Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.

Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S133-8.

PMID:
9663636
7.

[Needle exchange programs are a cost-effective preventative measure against HIV in Iceland].

Eythórsson ES, Ásgeirsdóttir TL, Gottfređsson M.

Laeknabladid. 2014 Jul;100(7-8):379-83. Icelandic.

PMID:
25125435
8.

Optimal provision of needle and syringe programmes for injecting drug users: A systematic review.

Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA.

Int J Drug Policy. 2010 Sep;21(5):335-42. doi: 10.1016/j.drugpo.2010.02.001. Epub 2010 Feb 26. Review.

PMID:
20189375
9.

Needle and syringe programs in Yunnan, China yield health and financial return.

Zhang L, Yap L, Xun Z, Wu Z, Wilson DP.

BMC Public Health. 2011 Apr 21;11:250. doi: 10.1186/1471-2458-11-250.

10.

Is Vancouver Canada's supervised injection facility cost-saving?

Pinkerton SD.

Addiction. 2010 Aug;105(8):1429-36. doi: 10.1111/j.1360-0443.2010.02977.x.

PMID:
20653622
11.

Needle exchange programs: an economic evaluation of a local experience.

Gold M, Gafni A, Nelligan P, Millson P.

CMAJ. 1997 Aug 1;157(3):255-62.

12.

The cost-effectiveness of Vancouver's supervised injection facility.

Bayoumi AM, Zaric GS.

CMAJ. 2008 Nov 18;179(11):1143-51. doi: 10.1503/cmaj.080808.

13.

Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.

van Beek I, Chronister KJ.

Int J Drug Policy. 2015 Sep;26(9):868-74. doi: 10.1016/j.drugpo.2015.05.009. Epub 2015 Jun 3.

PMID:
26118797
14.

Cost-effectiveness of syringe exchange as an HIV prevention strategy.

Laufer FN.

J Acquir Immune Defic Syndr. 2001 Nov 1;28(3):273-8.

PMID:
11694836
15.
16.

Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review.

Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, Horvath T, Kennedy GE, Des Jarlais DC.

AIDS Behav. 2013 Nov;17(9):2878-92. doi: 10.1007/s10461-013-0593-y. Review.

PMID:
23975473
17.

An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.

Lurie P, Gorsky R, Jones TS, Shomphe L.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S126-32.

PMID:
9663635
18.

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.

Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D.

Addiction. 2010 May;105(5):844-59. doi: 10.1111/j.1360-0443.2009.02888.x. Epub 2010 Mar 2. Review.

PMID:
20219055
19.

Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010.

Wiessing L, Likatavicius G, Hedrich D, Guarita B, van de Laar MJ, Vicente J.

Euro Surveill. 2011 Dec 1;16(48). pii: 20031. Erratum in: Euro Surveill. 2011;16(49).pii: 20037.

20.

Cost effectiveness of Streetworks' needle exchange program of Edmonton.

Jacobs P, Calder P, Taylor M, Houston S, Saunders LD, Albert T.

Can J Public Health. 1999 May-Jun;90(3):168-71.

PMID:
10401166

Supplemental Content

Support Center